Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03633825 · ClinicalTrials.gov registry record · NA

Brief Online Help-seeking Barrier Reduction Intervention

A NA study, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
39,450
Enrollment target

NCT03633825 is a NA study that has completed, run by Harvard University. The registered enrollment target is 39,450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03633825, a NA study, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
39,450 participants
Enrollment target

Study Summary

Objective: Mental illness is a leading cause of disease burden; however, many barriers prevent people from seeking mental health services. Technological innovations may improve the ability to reach under-served populations by overcoming many existing barriers. The investigators evaluated a brief, automated risk assessment and intervention platform designed to increase the use of crisis resources provided to individuals who were online and in crisis. Hypothesis: The investigators hypothesized that individuals assigned to the intervention condition would report using crisis resources at higher rates than individuals in the control condition. Method: Participants, users of the digital mental health app Koko, were randomly assigned to treatment or control conditions upon accessing the app and were included in the study after their posts were identified by machine learning classifiers as signaling a current mental health crisis. Participants in the treatment condition received a brief Barrier Reduction Intervention (BRI) designed to increase the use of crisis service referrals provided on the app. Participants were followed-up several hours later to assess the use of crisis services.

Interventions

  • BEHAVIORAL Brief help-seeking barrier reduction intervention

Trial Details

FieldValue
Enrollment Target 39,450 participants
Start Date 2017-08-10
Est. Completion 2017-09-20
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT03633825

The ClinicalTrials.gov registry entry for NCT03633825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39,450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Brief help-seeking barrier reduction intervention is the first listed.

NCT03633825 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03633825 about?

NCT03633825 is a clinical study titled "Brief Online Help-seeking Barrier Reduction Intervention". Objective: Mental illness is a leading cause of disease burden; however, many barriers prevent people from seeking mental health services. Technological innovations may improve the ability to reach under-served populations by overcoming many existing barriers. The investigators evaluated a brief, au...

What is the current status of trial NCT03633825?

This trial is currently completed. It is a NA study. The enrollment target is 39,450 participants. The study started on 2017-08-10. Estimated completion is 2017-09-20.

What interventions are being tested in trial NCT03633825?

The interventions under investigation include: Brief help-seeking barrier reduction intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03633825?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.